A ngiogenesis, a tightly regulated process of new blood vessel formation, is initiated when a select set of endothelial cells is stimulated to leave their quiescent state. 1 These cells become hypermigratory and form sprouts that guide the direction of vascular network development. 2 Formation of this ordered network depends on a regulated differentiation of the endothelial cells in which only specific endothelial cells can become sprouts. The consequence of dysregulation would be a failure to develop a cohesive vascular network. Examples of this can be seen in vascular diseases, such as CADASIL, and in tumor growth. 3, 4 Article, see p 1206
The vascular network forms when endothelial sprouts develop at the leading edge of the angiogenic front. These leading sprouts are known as the tip cells, characterized by filopodial expansions, which guide growth toward proangiogenic signals. Behind them are the stalk cells that provide a supporting network through proliferation and lumen formation. A critical component of angiogenesis is the maintenance of a proper balance between the number of tip and stalk cells.
The endothelial tip-stalk gradient is established when vascular endothelial growth factor (VEGF) is sensed by the endothelium. 5 Higher expression levels of VEGFR2/3 are found in tip cells, making them more responsive to VEGF stimulation and triggering the upregulation of the Notch ligand, Delta-like 4 (DLL4). The DLL4 produced by the tip cell signals to Notch expressed on the neighboring stalk cells, setting up a lateral inhibition gradient. It is this lateral inhibition that prevents the endothelial cells from becoming all tip or all stalk, thus allowing for proper tip cell migration and stalk cell expansion. 6 The phenomenon of notch-mediated lateral inhibition is not limited to the endothelium. Several other tissues, such as neural crest cells 7 and pancreatic ductal cells, 8 use this type of signaling for varying processes during fate determination and development. The concept of tip cell and stalk cell identity also expands beyond the endothelium and can be observed in most tissues that undergo branching morphogenesis. 9 However, despite the conservation of this type of later inhibition, most studies to date have focused on the interaction between the tip cell and the stalk cell, with little answered about how stalk cells interact with other stalk cells. The importance of DLL4 signaling in the tip is clear, but little is understood about what role DLL4 might play in the stalk.
In the angiogenic plexus, tip-stalk signaling establishes the direction of growth, but stalk-stalk signaling must support that growth. How exactly stalk cells signal to one another to maintain that identity in still undergoing investigation.
In this issue of Circulation Research, Adam et al 10 sought to answer questions of stalk-stalk signaling and to identify novel regulators of Notch signaling during sprouting angiogenesis. They began with a yeast-2-hybrid screen and identified Synaptojanin-2 binding protein (SYNJ2BP) as an interactor of DLL1 and DLL4. They proceeded to show that SYNJ2BP was expressed at high levels in stalk cells in an expression pattern that overlaps with expression pattern of both DLL1 and DLL4. Furthermore, in a subcutaneous endothelial spheroid xenograft model, loss of SYNJ2BP resulted in a higher vascular density. In contrast, forced overexpression of the protein resulted in the failure to form angiogenic sprouts in a mouse aortic ring sprouting assay. In the context of this sprouting assay, an inability of endothelial cells to sprout is considered antiangiogenic, whereas an antiangiogenic response is consistent with a prostalk cell phenotype. Therefore, SYNJ2BP was deemed to have prostalk functions. These angiogenic defects caused by modulation of SYNJ2BP are consistent with the defects observed when Notch signaling is modified. For example, when DLL4 is lost the vasculature has increased sprouting density, whereas overexpression of DLL4 reduces sprouting density. 11 How SYNJ2BP enacts its antiangiogenic role to promote the formation of stalk cells is found through its interaction with DLL1 and DLL4. When levels of SYNJ2BP are increased, so are the levels and the half-life of DLL1 and DLL4 protein. The time of half-life extension was similar to that of lysosome activity blocking. Therefore, the authors conclude that SYNJ2BP performs its prostalk role by preventing the degradation of DLL1 and DLL4 within the stalk cell, leading to increased Notch activity and continued lateral inhibition throughout the plexus 10 ( Figure) . The study presented by Adam et al provides important insight into the field of angiogenesis by discovering a novel mechanism of stalk cell-to-stalk cell signaling through SYNJ2BP as a stalk-specific regulator of DLL4. For angiogenesis and endothelial sprouting to occur properly, the VEGF-Delta-Notch signaling trifecta must be tightly calibrated, and pathways that can feed into this signaling loop can all influence endothelial tip/stalk fate. The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
From the University of Utah, Salt Lake City, UT. Correspondence to Tara M. Mleynek, University of Utah, Salt Lake City, UT. E-mail tara.mleynek@path.utah.edu levels enables stalk cells to maintain lateral inhibition within the vascular plexus, preventing aberrant tip cell formation and improper angiogenesis (Figure) .
How modulation of VEGF or other growth factors could affect stalk-stalk communication and plexus establishment is not well-understood. Recent work has shown that a flux in VEGF signaling can alter the levels of DLL4 and the acquisition of tip cell identity 12 ; therefore, it is possible that VEGF may play a role in regulating the levels of SYNJ2BP. In addition, further study is required to determine whether SYNJ2BP is regulated at the transcriptional level or by other potential upstream effectors.
Understanding the additional levels of regulation involved in angiogenesis is applicable to the development of antiangiogenic therapies. Several therapeutic options, such as inhibition of DLL4, have proven to be problematic and to have toxic side effects. 13, 14 By having a better grasp of how angiogenesis is regulated and how the vascular plexus is maintained, therapies targeting more specific angiogenic regulators could be developed. More importantly, the role of SYNJ2BP in endothelial stalk communication may extend to other tissue types that use Notch-mediated lateral inhibition during development, potentially providing insight into a conserved developmental signaling program. The identification of this novel DLL4 regulator highlights the need to look beyond tip-stalk and to understand stalkstalk signaling.
A final note is that the notion of tip and stalk is often presented as a static dichotomy. However, it is important to realize that this is not the case and that in reality there is a dynamicity to tip cells and stalk cells. These cells are often competing for the tip position, switching identity between tip and stalk until an eventual quiescence is achieved. 12 How SYNJ2BP and other factors may function in such a dynamic state is a key question in understanding how a population of cells can eventually become a mature and functional plexus.
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